BioCentury
ARTICLE | Financial News

ZS Pharma raised $55 million in D round

March 6, 2014 12:51 AM UTC

ZS Pharma Inc. (Coppell, Texas) raised $55 million in a series D round led by new investor Novo A/S. New investors RA Capital; Adage Capital; Sofinnova Ventures; and an additional undisclosed new investor also participated, along with existing investors Alta Partners; Devon Park Bioventures; 3x5 Special Opportunity Fund; Salem Partners; and RiverVest. ...